9 - David S Hui, Esam I Azhar, Tariq A Madani , Francine Ntoumi , Richard Kock , Osman Dar , Giuseppe Ippolito , Timothy D Mchugh , Ziad A Memish , Christian Drosten , Alimuddin Zumla , Eskild Petersen .2020. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China.. International Journal of Infectious diseases. .(2020) Feb;91:264-266.

8 - Najmul Haider , Alexei Yavlinsky , David Simons , Abdinasir Yusuf Osman, Francine Ntoumi, Alimuddin Zumla and Richard Kock. 2020. Passengers’ destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America. Epidemiology and Infection 148, e41, 1–7. https://doi.org/10.1017/S0950268820000424

7 - Ippolito G, Hui DS, Ntoumi F, Maeurer M, Zumla A. 2020. Toning down the 2019-nCoV media hype-and restoring hope. The Lancet Respiratory Medicine 2020 Mar;8(3):230-231. doi: 10.1016/S2213-2600(20)30070-9. Epub 2020 Feb 12.

6 - Petersen E, Hui D, Hamer DH, Blumberg L, Madoff LC, Pollack M, Lee SS, McLellan S, Memish Z, Praharaj I, Wasserman S, Ntoumi F, Azhar EI, Mchugh TD, Kock R, Ippolito G, Zumla A, Koopmans M. 2020. Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak. International Journal of Infectious Diseases. 2020 Mar 4;93:205-207. doi: 10.1016/j.ijid.2020.02.052.

5 - Kapata N, Ihekweazu C, Ntoumi F, Tajudeen R, Chanda-Kapata P, Mwaba P, Mukonka V, Bates M, Tembo J, Corman V, Mfinanga S, Asogun D, Elton L, Arruda LB, Thomason MJ, Mboera L, Yavlinsky A, Haider N, Simons D, Hollmann L, Lule SA, Veas F, Abdel Hamid MM, Dar O, Edwards S, Vairo F, McHugh TD, Drosten C, Kock R, Ippolito G, Zumla A. 2020. Is the Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic? - lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future. International Journal of Infectious Diseases. 2020 Feb 28. pii: S1201-9712(20)30107-7. doi: 10.1016/j.ijid.2020.02.049.

4 - Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Dupont HT, Honoré S, Colson P, Chabrière E, La Scola B, Rolain JM, Brouqui P, Raoult D. 2020. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Mar 20:105949. doi: 10.1016/j.ijantimicag.2020.105949. [Epub ahead of print]

3 - Li H, Zhou Y, Zhang M, Wang H, Zhao Q, Liu J.2020. Updated approaches against SARS-CoV-2. Antimicrob Agents Chemother. Antimicrob Agents Chemother. 2020 Mar 23. pii: AAC.00483-20. doi: 10.1128/AAC.00483-20. [Epub ahead of print] Review.

2 - Peto J. Covid-19 mass testing facilities could end the epidemic rapidly. BMJ 2020 Mar 22;368:m1163. doi: 10.1136/bmj.m1163. No abstract available

1 - Lai CC, Wang CY, Wang YH, Hsueh SC, Ko WC, Hsueh PR. 2020 Global epidemiology of coronavirus disease 2019: disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status. Int J Antimicrob Agents. 2020 Mar 18:105946. doi: 10.1016/j.ijantimicag.2020.105946. [Epub ahead of print]